I3C - References

Anonymous. 1997. Tamoxifen has a characteristic mutation spectrum in human endometrial cancers (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 38:A3008.
Arnao MB, et al. 1996. Indole-3-carbinol as a scavenger of free radicals. Biochem Mol Biol Int 39:1125-34.
Barakat RR, et al. 1997. Evaluation of p53, Bcl-2 and c-Ki-ras status in endometrial cancers occurring after breast cancer with or without tamoxifen treatment (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol 16:A1289.
Bitonti AJ, et al. 1999. US Patent 5,877,202.
Bradlow HL, et al. 1991. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-74.
Chen I, et al. 1996. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 51:1069-76.
Chen I, et al. 1998. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19:1631-9.
Cover CM, et al. 1998. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273:3838-47.
Cover M, et al. 1999. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. Cancer Res 59:1244-51.
Custodio JB, et al. 1994. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem Phearmacol 47:1989-98.
Devanaboyina U, et al. 1997. Effects of indole-3-carbinol (I3C) and phenethyl isothiocyanate (PEITC) on 7,12-dimethylbenz[a]anthracene (DMBA)-induced DNA adducts in rat mammary glands and liver (Meeting abstract). Proc Annu Meet am Assoc. Cancer Res 38:A2427.
Ferlini C, et al. 1999. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer 79:257-63.
Grubbs CJ, et al. 1995. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709-16.
Guillot C, et al. 1996. Alteration of p53 damage response by tamoxifen treatment. Clin Cancer Res 2:1439-44.
Gundimeda U, et al. 1996. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. Biol Chem 271:13504-14.
He YH, et al. 1997. Chemopreventive properties of indole-3-carbinol (I3C): inhibition of DNA adduct formation of the dietary carcinogen, 2-amino-1-methyl-6-pehnylimidazo [4,5-b]pyridine (PhIP), in female F344 rats. J Cell Biochem Suppl 27:42-51.
Lim JS, et al. 1992. Tamoxifen suppresses tumor promoter-induced hydrogen peroxide formation by human neutrophils. Cancer Res 52:4969-72.
Manson MM, et al. 1998. Chemoprevention of afatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver-predicting the outcome using early biomarkers. Carcinogenesis 19:1829-36.
Manz, et al. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338:959-64.
Michnovicz JJ, et al. 1991. Altered estrogen metabolism and excretion in humans following consumption of I3C. Nutr Cancer 16:59-66.
Michnovicz JJ, et al. 1997. Changes in levels of urinary estrogen metabolites after oral I3C treatment in humans. J Natl Cancer Inst 89:718-23.
Michnovicz JJ. 1998. Increased estrogen 2- hydroxylation in obese women using oral indole-3-carbinol. Int J Obes Relat Metab Disord 22:227-9.
Norris JD, et al. 1999. Peptide antagonists of the human estrogen receptor. Science 285:744-46.
Paige LA, et al. 1999. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA 96:3999-4004.
Ricci MS, et al. 1999. Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J Biol Chem 274:3430-38.
Schecter A, et al. 1997. Dioxins, dibenzofurans, dioxin-like PCBs and DDE in U.S. fast food, 1995. Chemosphere 34:1449-57.
Sharma S, et al. 1994. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer s 54:5848-55.
Shertzer HG, et al. 1988. Intervention in free radical mediated hepatotoxicity and lipid peroxidation by indole-3-carbinol. Biochem Pharmacol 37:333-38.
Taioli E, et al. 1997. Effects of indole-3-carbinol (I3C) on the metabolism of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers (Meeting abstract). Proc Annu Meet am Assoc Cancer Res 38:A1413.
Taioli E, et al. 1999. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev 23:232-7.
Telang NT, et al. 1997. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical I3C. Proc Soc Exp Biol Med 216:246-52.
Thangaraju M, et al. 1994. Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer 74:78-82.
Vancutsem PM, et al. 1994. Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res 54:3864-7.
Verhagen H, et al. 1995. Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis 16:969-70.
Verhoeven DT, et al. 1996. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 733-48.
Wattenberg LW, et al. 1978. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38:1410-13.
Wei H, et al. 1998. Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo. Carcinogenesis 19:1013-8.
Yang JH, et al. 1999. A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expression of growth regulatory factors. Carcinogenesis 20:13-18.